Observational studyBMC public health2025
HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany: a multicenter, observational, cross-sectional study.
Observational study in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMen who have sex with men (MSM), especially those living with HIV, have a high prevalence of HPV infections that might lead to HPV-related diseases, including penile, oropharyngeal and anal carcinomas. Currently, beyond recommendations to get vaccinated during childhood, adult MSM are not included in the German national HPV vaccination recommendation. The aim of this cross-sectional study was to assess knowledge of HPV and HPV vaccination, and further acceptance and uptake of HPV vaccination among MSM in Germany.
methodsParticipants were recruited between 10/2023 and 07/2024 at 10 German study sites specialized on sexual and/or men's health. Main inclusion criteria were being MSM, being aged 18-45 years and a German health insurance. Data were obtained through an electronic questionnaire and analyzed descriptively. 20 HPV and 5 HPV vaccination knowledge questions were evaluated using sum scores, with each correct answer scoring 1 point.
results929 participants, aged 18-45 years (median 31), were included in the analysis. 122 (13.1%) were living with HIV and 717 (77.2%) used HIV-PrEP. 731 (78.7%) had prior knowledge of HPV, and 604 (65.0%) were aware of HPV vaccination. Mean sum scores for HPV knowledge (N = 731) and HPV vaccination knowledge questions (N = 604) were 13.3 ± 4.3 and 3.0 ± 1.3, respectively. Among those aware of HPV vaccination, 377 (62.4%) accepted vaccination (defined as already vaccinated (N = 204) or intending to get vaccinated (N = 173), and 223 (36.9%) participants were hesitant. Main reasons for hesitancy included a lack of information and no mandatory reimbursement of adult HPV vaccination costs. For MSM who intended to get vaccinated, payment out of pocket and missing physician recommendations were the main reasons for not being vaccinated yet. Among all analyzed MSM (N = 929), 127 (13.7%) completed a full vaccination schedule (21% within those aware of HPV vaccination).
conclusionDespite almost 80% participants being aware of HPV, vaccination uptake was low among all participants. More information about HPV, i.e., through physicians and social networks, might support informed decision-making. Further, facilitating access by offering reimbursement options for vaccination could potentially be a factor to help increase HPV vaccination uptake among MSM in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.